NSE · NATHBIOGEN · FMCG
Nath Bio-Genes (India) Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹46 Cr with net profit ₹4 Cr — a 8.3% net margin, versus 10.96% the period before.
Shareholding
As of 2026-06-30
- Promoter45.6%
- Public54.13%
- FII0.27%
- DII0.01%
32,564 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.62× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Miscellaneous · ranked #158 of 530 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Ports & Special Economic Zone Ltd. | ₹3,96,212 Cr | 119.01 | 4.12 | 13.32% | 33.06% |
| Eternal Limited | ₹3,00,898 Cr | 1641.05 | 9.25 | 1.18% | 0.67% |
| BSE Limited | ₹1,44,241 Cr | 183.02 | 21.65 | 37.42% | 51.66% |
| GAIL (India) Ltd. | ₹1,15,143 Cr | 77.49 | 1.29 | 8.51% | 5.34% |
| GMR Airports Limited | ₹1,13,087 Cr | 369.31 | — | -10.6% | 1.19% |
| Mazagon Dock Shipbuilders Ltd. | ₹93,092 Cr | 137.04 | 9.54 | 26.48% | 21.23% |
| One 97 Communications Ltd. | ₹85,165 Cr | 463.41 | 5.31 | 4.55% | 6.55% |
| Meesho Limited | ₹82,526 Cr | — | 18.67 | -28.13% | -10.75% |
| Info Edge (India) Ltd. | ₹80,913 Cr | 142.94 | 2.13 | 3.82% | 0.44% |
| Swiggy Limited | ₹79,315 Cr | — | 4.33 | -22.68% | -18.02% |
| Nath Bio-Genes (India) Ltd.(this company) | ₹304 Cr | 7.18 | 0.45 | 5.32% | 9.82% |
AI analysis
AI-generated · google/gemini-2.5-flashNath Bio-Genes (India) Ltd. is listed with a market capitalization of Rs 311 Cr. The company reported a revenue of Rs 369.45 Cr and a profit margin of 9.82%. The earnings per share (EPS) stood at Rs 19.06. The company’s 52-week high was Rs 204 and its 52-week low was Rs 126.15.
Positives
- +The company's revenue growth stood at 9.7% for the reported period, reaching Rs 369.45 Cr.
- +The debt-to-equity ratio is low at 0.19, indicating limited reliance on debt financing.
- +The promoter holding of 45.60% as of Mar 2026 suggests significant insider ownership.
Negatives
- −The company experienced a negative net profit of -Rs 0.01 Cr in March 2026.
- −The promoter pledge level was 13.78% as of March 31, 2026.
Financial Performance
Nath Bio-Genes (India) Ltd. reported a revenue of Rs 369.45 Cr, reflecting a revenue growth of 9.7%. The net profit for the period was not directly provided, but the profit margin was 9.82%.
Profitability & Returns
The company's profitability is indicated by an EPS of Rs 19.06 and a profit margin of 9.82%. Return on equity (ROE) was 5.32%, and return on capital employed (ROCE) was 6.87%.
Balance Sheet
Nath Bio-Genes (India) Ltd. has a debt-to-equity ratio of 0.19, with a book value per share of Rs 358.06.
Ownership & Pledges
As of March 31, 2026, promoters held 45.59% of the company's shares. Public shareholding was 54.17%, FIIs held 0.23%, and DIIs held 0.01%. A portion of the promoter's shares, specifically 13.78%, was pledged.
Quarterly Performance
In Q1 FY26 (Jun 2025), Nath Bio-Genes (India) Ltd. generated revenue of Rs 283.7 Cr and a net profit of Rs 37.28 Cr. However, in Q4 FY26 (Mar 2026), the company's net profit was -Rs 0.01 Cr, despite revenue of Rs 51.59 Cr.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Nath Bio-Genes (India) Ltd.share price & fundamentals